Structure and function of Gab2 and its role in cancer (Review)
Open accessAbstract
The docking proteins of the Grb-associated binder (Gab) family transduce cellular signals between receptors and intracellular downstream effectors, and provide a platform for protein‑protein interactions. Gab2, a key member of the Gab family of proteins, is involved in the amplification and integration of signal transduction, evoked by a variety of extracellular stimuli, including growth factors, cytokines and antigen receptors. Gab2 protein lacks intrinsic catalytic activity; however, when phosphorylated by protein‑tyrosine kinases (PTKs), Gab2 recruits several Src homology‑2 (SH2) domain‑containing proteins, including the SH2‑containing protein tyrosine phosphatase 2 (SHP2), the p85 subunit of phosphoinositide‑3 kinase (PI3K), phospholipase C‑γ (PLCγ)1, Crk, and GC‑GAP. Through these interactions, the Gab2 protein triggers various downstream signal effectors, including SHP2/rat sarcoma viral oncogene/RAF/mitogen‑activated protein kinase kinase/extracellular signal‑regulated kinase and PI3K/AKT, involved in cell growth, differentiation, migration and apoptosis. It has been previously reported that aberrant Gab2 and/or Gab2 signaling is closely associated with human tumorigenesis, particularly in breast cancer, leukemia and melanoma. The present review aimed to focus on the structure and effector function of Gab2, its role in cancer and its potential for use as an effective therapeutic target.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Many cell signaling pathways require large multi-site docking proteins to transduce signal from the activated receptor to downstream intracellular effectors.
“Many cell signaling pathways require large multi-site docking proteins to transduce signal from the activated receptor to downstream intracellular effectors [305].”
From Intrinsically disordered proteins play diverse roles in cell signaling (2022) · cites this paper as [305]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674 · see citing works
The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
Neel, B. G., Gu, H., & Pao, L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00091-4 · Cited by 1,249 · see citing works
Tartaglia, M., Niemeyer, C. M., Fragale, A., Song, X., Buechner, J., Jung, A., Hählen, K., Hasle, H., Licht, J. D., & Gelb, B. D. (2003) · Nature Genetics · doi:10.1038/ng1156 · Cited by 1,033 · see citing works
A Grb2-associated docking protein in EGF- and insulin-receptor signalling
Holgado-Madruga, M., Emlet, D. R., Moscatello, D. K., Godwin, A. K., & Wong, A. J. (1996) · Nature · doi:10.1038/379560a0 · Cited by 677 · see citing works
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Abrams, S. L., Lee, J. T., Chang, F., Bertrand, F. E., Navolanic, P. M., Terrian, D. M., Franklin, R. A., D’Assoro, A. B., et al. (2006) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.01.004 · Cited by 656 · see citing works
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Loh, M. L. (2003) · Blood · doi:10.1182/blood-2003-09-3287 · Cited by 422 · see citing works
The ‘Gab’ in signal transduction
Gu, H., & Neel, B. G. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00002-3 · Cited by 389 · see citing works
Critical role for Gab2 in transformation by BCR/ABL
Sattler, M., Mohi, G., Pride, Y. B., Quinnan, L. R., Malouf, N. A., Podar, K., Gesbert, F., Iwasaki, H., Li, S., Etten, R. A. V., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00074-0 · Cited by 364 · see citing works
PTPN11 (Shp2) Mutations in LEOPARD Syndrome Have Dominant Negative, Not Activating, Effects
Kontaridis, M. I., Swanson, K. D., David, F. S., Barford, D., & Neel, B. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m513068200 · Cited by 340 · see citing works
Essential role for Gab2 in the allergic response
Gu, H., Saito, K., Klaman, L. D., Shen, J., Fleming, T., Wang, Y., Pratt, J. C., Lin, G., Lim, B., Kinet, J., et al. (2001) · Nature · doi:10.1038/35084076 · Cited by 304 · see citing works
Gu, H., Pratt, J. C., Burakoff, S. J., & Neel, B. G. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80288-9 · Cited by 304 · see citing works
Diverse Biochemical Properties of Shp2 Mutants
Keilhack, H., David, F. S., McGregor, M. J., Cantley, L. C., & Neel, B. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504699200 · Cited by 299 · see citing works
Maroun, C. R., Naujokas, M. A., Holgado-Madruga, M., Wong, A. J., & Park, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8513-8525.2000 · Cited by 286 · see citing works
Mohi, G., Williams, I. R., Dearolf, C. R., Chan, G., Kutok, J. L., Cohen, S. L., Morgan, K. J., Boulton, C. L., Shigematsu, H., Keilhack, H., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.010 · Cited by 274 · see citing works
New Role for Shc in Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway
Gu, H., Maeda, H., Moon, J. J., Lord, J. D., Yoakim, M., Nelson, B. H., & Neel, B. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7109-7120.2000 · Cited by 267 · see citing works
Nishida, K., Yoshida, Y., Itoh, M., Fukada, T., Ohtani, T., Shirogane, T., Atsumi, T., Takahashi-Tezuka, M., Ishihara, K., Hibi, M., et al. (1999) · Blood · doi:10.1182/blood.v93.6.1809.406k35_1809_1816 · Cited by 239 · see citing works
An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells
Sheng, Q., Liu, X., FLEMING, E. M., Yuan, K., Piao, H., Chen, J., MOUSTAFA, Z. R., Thomas, R. K., Greulich, H. E., Schinzel, A. C., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.047 · Cited by 234 · see citing works
Kotecha, N., Flores, N. J., Irish, J. M., Simonds, E. F., Sakai, D. S., Archambeault, S., Díaz-Flores, E., Coram, M., Shannon, K., Nolan, G. P., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.08.014 · Cited by 233 · see citing works
A role for the scaffolding adapter GAB2 in breast cancer
Bentires‐Alj, M., Gil, S. G., Chan, R., Wang, Z. C., Wang, Y., Imanaka, N., Harris, L. N., Richardson, A. L., Neel, B. G., & Gu, H. (2005) · Nature Medicine · doi:10.1038/nm1341 · Cited by 210 · see citing works
A Novel Role for Gab1 and SHP2 in Epidermal Growth Factor-induced Ras Activation
Montagner, A., Yart, A., Dance, M., Perret, B., Salles, J., & Raynal, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410012200 · Cited by 205 · see citing works
Lock, L. S., Royal, I., Naujokas, M. A., & Park, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003597200 · Cited by 189 · see citing works
Function, regulation and pathological roles of the Gab/DOS docking proteins
Wöhrle, F. U., Daly, R. J., & Brummer, T. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-22 · Cited by 171 · see citing works
Amplification of 11q13 in ovarian carcinoma
Brown, L. A., Kalloger, S. E., Miller, M. A., Shih, I., McKinney, S. E., Santos, J. L., Swenerton, K., Spellman, P. T., Gray, J. W., Gilks, C. B., et al. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20549 · Cited by 160 · see citing works
Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis
Qian, P., Zuo, Z., Wu, Z., Meng, X., Li, G., Wu, Z., Zhang, W., Tan, S. H., Pandey, V., Yao, Y., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1322 · Cited by 153 · see citing works
Requirement of Gab2 for mast cell development and KitL/c-Kit signaling.
Nishida, K., Wang, L., Morii, E., Park, S. J., Narimatsu, M., Itoh, S., Yamasaki, S., Fujishima, M., Ishihara, K., Hibi, M., et al. (2002) · Blood · doi:10.1182/blood.v99.5.1866 · Cited by 148 · see citing works
A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review)
Fan, Y., Zheng, M. H., TANG, Y.-L., & Liang, X. (2013) · Oncology Letters · doi:10.3892/ol.2013.1555 · Cited by 136 · see citing works
RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy
Yajima, I., Kumasaka, M. Y., Thang, N. D., Goto, Y., Takeda, K., Yamanoshita, O., Iida, M., Ohgami, N., Tamura, H., Kawamoto, Y., et al. (2011) · Dermatology Research and Practice · doi:10.1155/2012/354191 · Cited by 136 · see citing works
Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia
Emanuel, P. D. (2008) · Leukemia · doi:10.1038/leu.2008.162 · Cited by 127 · see citing works
Brummer, T., Schramek, D., Hayes, V. M., Bennett, H. L., Caldon, C. E., Musgrove, E. A., & Daly, R. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509567200 · Cited by 124 · see citing works
Nyga, R., Pecquet, C., Harir, N., Gu, H., Duthille, I., Régnier, A., Gouilleux‐Gruart, V., Lassoued, K., & Gouilleux, F. (2005) · Biochemical Journal · doi:10.1042/bj20041523 · Cited by 118 · see citing works
Scherr, M., Chaturvedi, A., Battmer, K., Dallmann, I., Schultheis, B. S., Ganser, A., & Eder, M. (2005) · Blood · doi:10.1182/blood-2005-08-3087 · Cited by 111 · see citing works
Sha, F., Akçok, E. B. G., Georgeon, S., Koide, A., Yasui, N., Koide, S., & Hantschel, O. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303640110 · Cited by 104 · see citing works
Janus kinase 2 regulates Bcr–Abl signaling in chronic myeloid leukemia
Samanta, A., Perazzona, B., Chakraborty, S., Sun, X., Modi, H., Bhatia, R., Priebe, W., & Arlinghaus, R. B. (2010) · Leukemia · doi:10.1038/leu.2010.287 · Cited by 97 · see citing works
Engagement of Gab1 and Gab2 in Erythropoietin Signaling
Wickrema, A., Shahab Uddin, M. S., Sharma, A. K., Chen, F., Alsayed, Y. M., Ahmad, S., Sawyer, S. T., Krystal, G., Yi, T., Nishada, K., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.24469 · Cited by 97 · see citing works
Inherited predispositions and hyperactive Ras in myeloid leukemogenesis
Lauchle, J. O., Braun, B. S., Loh, M. L., & Shannon, K. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20644 · Cited by 94 · see citing works
Hibi, M., & Hirano, T. (2000) · Leukemia and Lymphoma · doi:10.3109/10428190009089430 · Cited by 94 · see citing works
Yu, M., Luo, J., Yang, W., Wang, Y., Mizuki, M., Kanakura, Y., Besmer, P., Neel, B. G., & Gu, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603742200 · Cited by 90 · see citing works
Self-citationScaffolding Adapter Grb2-Associated Binder 2 Requires Syk to Transmit Signals from FcεRI
Yu, M., Lowell, C., Neel, B. G., & Gu, H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2421 · Cited by 89 · see citing works
GAB2—a Scaffolding Protein in Cancer
Adams, S. J., Aydin, I. T., & Celebi, J. T. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0352 · Cited by 88 · see citing works
Sármay, G., Angyal, A., Kertész, Á., Maus, M., & Medgyesi, D. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.11.017 · Cited by 86 · see citing works
Role of Gab2 in mammary tumorigenesis and metastasis
Ke, Y., Wu, D., Princen, F., Nguyen, T., Pang, Y., Lesperance, J., Muller, W. J., Oshima, R. G., & Feng, G.-S. (2007) · Oncogene · doi:10.1038/sj.onc.1210315 · Cited by 84 · see citing works
Gab2-Mediated Signaling Promotes Melanoma Metastasis
Horst, B. A. J., Gruvberger-Saal, S. K., Hopkins, B. D., Bordone, L. A., Yang, Y., Chernoff, K. A., Uzoma, I. C., Schwipper, V., Liebau, J., Nowak, N. J., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080543 · Cited by 84 · see citing works
Maulik, G., Madhiwala, P., Brooks, S., C., P., Kijima, T., Tibaldi, E. V., SCHAEFER, E. M., Parmar, K., & Salgia, R. (2002) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2002.tb00453.x · Cited by 83 · see citing works
Heuser, M., Sly, L. M., Argiropoulos, B., Kuchenbauer, F. C., Lai, C. K., Weng, A. P., Leung, M., Lin, G., Brookes, C., Fung, S., et al. (2009) · Blood · doi:10.1182/blood-2009-06-227603 · Cited by 77 · see citing works
Wang, Y., Sheng, Q., Spillman, M. A., Behbakht, K., & Gu, H. (2011) · Oncogene · doi:10.1038/onc.2011.435 · Cited by 75 · see citing works
Focal amplification and oncogene dependency of GAB2 in breast cancer
Bocanegra, M. C., Bergamaschi, A., Kim, Y. H., Miller, M. A., Rajput, A. B., Kao, J., Langerød, A., Han, W., Noh, D. Y., Jeffrey, S. S., et al. (2009) · Oncogene · doi:10.1038/onc.2009.364 · Cited by 68 · see citing works
Phosphorylation‐dependent binding of 14‐3‐3 terminates signalling by the Gab2 docking protein
Brummer, T., Larance, M., Abreu, M. T. H., Lyons, R. J., Timpson, P., Emmerich, C. H., Fleuren, E. D. G., Lehrbach, G. M., Schramek, D., Guilhaus, M., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.159 · Cited by 61 · see citing works
Davis, S. J., Sheppard, K. E., Pearson, R. B., Campbell, I., Gorringe, K. L., & Simpson, K. J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3433 · Cited by 60 · see citing works
GAB2 Amplifications Refine Molecular Classification of Melanoma
Chernoff, K. A., Bordone, L. A., Horst, B. A. J., Simon, K., Twadell, W. S., Lee, K., Cohen, J. A., Wang, S., Silvers, D. N., Brunner, G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0280 · Cited by 59 · see citing works
Carlberg, K., & Rohrschneider, L. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15943 · Cited by 56 · see citing works
Mali, R. S., Ma, P., Zeng, L., Martin, H., Ramdas, B., He, Y., Sims, E. K., Nabinger, S. C., Ghosh, J., Sharma, N., et al. (2012) · Blood · doi:10.1182/blood-2011-08-375873 · Cited by 55 · see citing works
Yu, W., Hawley, T. S., Hawley, R. G., & Qu, C. (2002) · Blood · doi:10.1182/blood.v99.7.2351 · Cited by 54 · see citing works
Self-citationGAB2 is a novel target of 11q amplification in AML/MDS
Zaťková, A., Schoch, C., Speleman, F., Poppe, B. G., Mannhalter, C., Fonatsch, C., & Wimmer, K. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20344 · Cited by 54 · see citing works
Simister, P. C., & Feller, S. M. (2011) · Molecular BioSystems · doi:10.1039/c1mb05272a · Cited by 54 · see citing works
Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors
Wöhrle, F. U., Halbach, S., Aumann, K., Schwemmers, S., Braun, S. L., Auberger, P., Schramek, D., Penninger, J. M., Laßmann, S., Werner, M., et al. (2012) · Leukemia · doi:10.1038/leu.2012.222 · Cited by 53 · see citing works
Crouin, C., Arnaud‐Arnould, M., Gesbert, F., Camonis, J., & Bertoglio, J. H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02373-0 · Cited by 53 · see citing works
Yu, W., Daino, H., Chen, J., Bunting, K. D., & Qu, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507622200 · Cited by 51 · see citing works
Self-citationPhosphoinositide 3‐kinase‐regulated adapters in lymphocyte activation
Zhang, T., Li, H., Cheung, S., Costantini, J. L., Hou, S., Al-Alwan, M. M., & Marshall, A. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00838.x · Cited by 50 · see citing works
Abnormal hematopoiesis in Gab2 mutant mice
Zhang, Y., Díaz-Flores, E., Li, G., Wang, Z., Kang, Z., Haviernikova, E., Rowe, S. L., Qu, C., Tse, W., Shannon, K., et al. (2007) · Blood · doi:10.1182/blood-2006-11-060707 · Cited by 49 · see citing works
GC-GAP, a Rho Family GTPase-activating Protein That Interacts with Signaling Adapters Gab1 and Gab2
Zhao, C., Ma, H., Bossy‐Wetzel, E., Lipton, S. A., Zhang, Z., & Feng, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304594200 · Cited by 49 · see citing works
Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis
Jiang, X., Cheng, Q., Yi, B., & Wang, A. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s52730 · Cited by 48 · see citing works
Lee, S. H., Jeong, E. G., Nam, S. W., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2007) · Pathology · doi:10.1080/00313020701329773 · Cited by 46 · see citing works
In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene
Dunn, G. P., Cheung, H. W., Agarwalla, P. K., Thomas, S. R., Zektser, Y. A., Karst, A. M., Boehm, J. S., Weir, B. A., Berlin, A. M., Zou, L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311909111 · Cited by 43 · see citing works
Ding, J., Romani, J., Zaborski, M., MacLeod, R. A. F., Nagel, S., Drexler, H. G., & Quentmeier, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083510 · Cited by 40 · see citing works
Overexpression of Grb2-associated Binder 2 in Human Lung Cancer
Xu, X.-L., Wang, X., Chen, Z., Jin, M., Wu, Y. B., Zhao, G., & Lǐ, J. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.496 · Cited by 38 · see citing works
Gab2 expression in glioma and its implications for tumor invasion
Shi, L., Sun, X., Zhang, J., Zhao, C., Li, H., Liu, Z., Fang, C., Wang, X., Zhao, C., Zhang, X., et al. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.750032 · Cited by 36 · see citing works
A Crk-II/TC10 Signaling Pathway Is Required For Osmotic Shock-stimulated Glucose Transport
Gual, P., Shigematsu, S., Kanzaki, M., Grémeaux, T., Gonzalez, T., Pessin, J. E., MARCHAND‐BRUSTEL, Y. L., & Tanti, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203042200 · Cited by 34 · see citing works
Gab2 Phosphorylation by RSK Inhibits Shp2 Recruitment and Cell Motility
Zhang, X., Lavoie, G., Fort, L., Huttlin, E. L., Tcherkezian, J., Galan, J. A., Gu, H., Gygi, S. P., Carreno, S., & Roux, P. P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01353-12 · Cited by 34 · see citing works
Overexpression of the oncogenic signal transducer Gab2 occurs early in breast cancer development
Fleuren, E. D. G., O'Toole, S. A., Millar, E. K. A., McNeil, C. M., López‐Knowles, E., Boulghourjian, A., Croucher, D. R., Schramek, D., Brummer, T., Penninger, J. M., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25172 · Cited by 34 · see citing works
Ni, S., Zhao, C., Feng, G., Paulson, R. F., & Correll, P. H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01838-06 · Cited by 33 · see citing works
GAB2 induces tumor angiogenesis in NRAS-driven melanoma
Yang, Y., Wu, J., Demir, A., Castillo-Martín, M., Melamed, R., Zhang, G., Fukunaga‐Kalabis, M., Pérez‐Lorenzo, R., Zheng, B., Silvers, D. N., et al. (2012) · Oncogene · doi:10.1038/onc.2012.367 · Cited by 32 · see citing works
Teal, H. E., Ni, S., Xu, J., Finkelstein, L. D., Cheng, A. M., Paulson, R. F., Feng, G.-S., & Correll, P. H. (2005) · Oncogene · doi:10.1038/sj.onc.1209288 · Cited by 31 · see citing works
The Gab2 in signal transduction and its potential role in the pathogenesis of Alzheimer’s disease
Pan, X., Ren, R., Wang, G., Tang, H., & Chen, S. (2010) · Neuroscience Bulletin · doi:10.1007/s12264-010-1109-7 · Cited by 27 · see citing works
Tripathi, A., & Sodhi, A. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.013 · Cited by 27 · see citing works
Abreu, M. T. H., Hughes, W. E., Mele, K., Lyons, R. J., Rickwood, D., Browne, B. C., Bennett, H. L., Vallotton, P., Brummer, T., & Daly, R. J. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-03-0185 · Cited by 26 · see citing works
Nasrazadani, A., & Berg, C. L. V. D. (2011) · Genes & Cancer · doi:10.1177/1947601911400901 · Cited by 26 · see citing works
Nagao, T., Kurosu, T., Umezawa, Y., Nogami, A., Oshikawa, G., Tohda, S., Yamamoto, M., & Miura, O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084746 · Cited by 25 · see citing works
Grb2 associated binder 2 couples B-cell receptor to cell survival
Maus, M., Medgyesi, D., Kövesdi, D., Csuka, D., Koncz, G., & Sármay, G. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.002 · Cited by 20 · see citing works
Aumann, K., Laßmann, S., Schöpflin, A., May, A. M., Wöhrle, F. U., Zeiser, R., Waller, C. F., Hauschke, D., Werner, M., & Brummer, T. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.09.012 · Cited by 20 · see citing works
Gu, H. et al. Essential role for Gab2 in the allergic response. Nature 412, 186-190
Hh, G., Saito, K., Klaman, L. D., Jq, S., Fleming, T., Wang, Y., Pratt, J. C., Lin, G., Lim, B., Kinet, J., et al. (2001) · Cited by 20 · see citing works
Zhang, X. Z., Zhang, Y., Tao, B., Wang, D., Cheng, H., Wang, K., Zhou, R., Xie, Q.-M., & Ke, Y. (2012) · The FASEB Journal · doi:10.1096/fj.12-211755 · Cited by 19 · see citing works
Halbach, S., Rigbolt, K. T. G., Wöhrle, F. U., Diedrich, B., Gretzmeier, C., Brummer, T., & Dengjel, J. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-30 · Cited by 18 · see citing works
Wöhrle, F. U., Daly, R. J., & Brummer, T. (2009) · Structure · doi:10.1016/j.str.2009.05.003 · Cited by 12 · see citing works
Interleukin-3 (IL-3)-induced c-fos Activation Is Modulated by Gab2-Calcineurin Interaction
Pyarajan, S., Matejovic, G., Pratt, J. C., Baksh, S., & Burakoff, S. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800087200 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Intrinsically disordered proteins play diverse roles in cell signaling
Bondos, S. E., Dunker, A. K., & Uversky, V. N. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00821-7 · Cited by 222 · see citing works
FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications
Kazi, J. U., & Rönnstrand, L. (2019) · Physiological Reviews · doi:10.1152/physrev.00029.2018 · Cited by 216 · see citing works
Alves, R., Gonçalves, A. C., Rutella, S., Almeida, A. M., De Las Rivas, J., Trougakos, I. P., & Sarmento Ribeiro, A. B. (2021) · Cancers · doi:10.3390/cancers13194820 · Cited by 204 · see citing works
Curcumin can improve Parkinson's disease via activating BDNF/PI3k/Akt signaling pathways
Jin, T., Zhang, Y., Botchway, B. O. A., Zhang, J., Fan, R., Zhang, Y., & Liu, X. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113091 · Cited by 110 · see citing works
Wang, L., Zhang, Z.-T., Wang, L., Wei, H., Zhang, T., Zhang, L., Lin, H., Zhang, H., & Wang, S. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04890-x · Cited by 87 · see citing works
Therapeutic potential of targeting SHP2 in human developmental disorders and cancers
Shen, D., Chen, W., Zhu, J., Wu, G., Shen, R., Xi, M., & Sun, H. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112117 · Cited by 78 · see citing works
Ding, C., Luo, J., Li, L., Li, S., Yang, L., Pan, H., Liu, Q., Qin, H., Chen, C., & Feng, J. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0280-0 · Cited by 71 · see citing works
Self-citationKe, M., Yuan, X. N., He, A., Yu, P., Chen, W., Shi, Y., Hunter, T. R., Zou, P., & Tian, R. (2021) · Nature Communications · doi:10.1038/s41467-020-20367-x · Cited by 67 · see citing works
A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus
Lanata, C. M., Paranjpe, I., Nititham, J., Taylor, K. E., Gianfrancesco, M. A., Paranjpe, M. D., Andrews, S. V., Chung, S. A., Rhead, B. L., Barcellos, L. F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11845-y · Cited by 65 · see citing works
SH2 Domains: Folding, Binding and Therapeutical Approaches
Diop, A., Santorelli, D., Malagrinò, F., Nardella, C., Pennacchietti, V., Pagano, L., Marcocci, L., Pietrangeli, P., Gianni, S., & Toto, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415944 · Cited by 60 · see citing works
Ding, C., Li, L., Yang, T., Fan, X., & Wu, G. (2016) · BMC Cancer · doi:10.1186/s12885-016-2834-8 · Cited by 56 · see citing works
Self-citationLipid quantification by Raman microspectroscopy as a potential biomarker in prostate cancer
O’Malley, J., Kumar, R., Kuzmin, A. N., Pliss, A., Yadav, N., Balachandar, S., Wang, J., Attwood, K. M., Prasad, P. N., & Chandra, D. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.025 · Cited by 52 · see citing works
The Gab2–MALT1 axis regulates thromboinflammation and deep vein thrombosis
Kondreddy, V. K. R., Keshava, S., Das, K., Magisetty, J., Rao, L. V. M., & Pendurthi, U. R. (2022) · Blood · doi:10.1182/blood.2022016424 · Cited by 44 · see citing works
Ding, C., Luo, J., Fan, X., Li, L., Li, S., Wen, K., Feng, J., & Wu, G. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0524-2 · Cited by 42 · see citing works
Self-citationSeviiri, M., Law, M. H., Ong, J., Gharahkhani, P., Fontanillas, P., Aslibekyan, S. W., Auton, A., Babalola, E., Bell, R. K., Bielenberg, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35345-8 · Cited by 42 · see citing works
SHP2 is required for BCR-ABL1-induced hematologic neoplasia
Gu, S. S., Sayad, A., Chan, G., Yang, W., Lu, Z., Virtanen, C., Etten, R. A. V., & Neel, B. G. (2017) · Leukemia · doi:10.1038/leu.2017.250 · Cited by 37 · see citing works
Dorsal ruffles enhance activation of Akt by growth factors
Yoshida, S., Pacitto, R., Sesi, C., Kotula, L., & Swanson, J. A. (2018) · Journal of Cell Science · doi:10.1242/jcs.220517 · Cited by 35 · see citing works
GAB2 promotes cell proliferation by activating the ERK signaling pathway in hepatocellular carcinoma
Chen, Y., Liu, Q., Wu, M., Li, M., Ding, H., Shan, X., Liu, J., Tao, T., Ni, R., & Chen, X. (2016) · Tumor Biology · doi:10.1007/s13277-016-5019-9 · Cited by 30 · see citing works
Yamaoka, T., Ohmori, T., Ohba, M., Arata, S., Kishino, Y., Murata, Y., Kusumoto, S., Ishida, H., Shirai, T., Hirose, T., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0313 · Cited by 32 · see citing works
Yu, S., Geng, S., & Hu, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9053 · Cited by 29 · see citing works
IL-1RAP, a Key Therapeutic Target in Cancer
Frenay, J., Bellaye, P., Oudot, A., Helbling, A., Petitot, C., Ferrand, C., Collin, B., & Dias, A. M. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314918 · Cited by 29 · see citing works
Gab2 mediates hepatocellular carcinogenesis by integrating multiple signaling pathways
Cheng, J., Zhong, Y., Chen, S., Sun, Y., Huang, L., Kang, Y., Chen, B., Chen, G., Wang, F., Tian, Y., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700120rr · Cited by 27 · see citing works
Heger, Z., Polanska, H. H., Rodrigo, M. Á. M., Guráň, R., Kulich, P., Kopel, P., Masařík, M., Eckschlager, T., Stiborová, M., Kizek, R., et al. (2016) · Scientific Reports · doi:10.1038/srep33379 · Cited by 26 · see citing works
Shi, X., Gong, L., Liu, Y., Hou, K., Fan, Y., Li, C., Wen, T., Qu, X., & Che, X. (2019) · Epigenetics · doi:10.1080/15592294.2019.1700032 · Cited by 22 · see citing works
Classical Angiogenic Signaling Pathways and Novel Anti-Angiogenic Strategies for Colorectal Cancer
Cao, M., Wang, Y., Lu, G., Qi, H., Li, P., Dai, X., & Lü, J. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100305 · Cited by 22 · see citing works
Kondreddy, V. K. R., Magisetty, J., Keshava, S., Rao, L. V. M., & Pendurthi, U. R. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316153 · Cited by 22 · see citing works
Functions of genes related to testicular germ cell tumour development
Das, M. K., Kleppa, L., & Haugen, T. B. (2019) · Andrology · doi:10.1111/andr.12663 · Cited by 19 · see citing works
GAB2 Amplification in Squamous Cell Lung Cancer of Non-Smokers
Park, Y. R., Bae, S. H., Ji, W., Seo, E., Lee, J. C., Kim, H. R., Jang, S. J., & Choi, C. (2017) · Journal of Korean Medical Science · doi:10.3346/jkms.2017.32.11.1784 · Cited by 17 · see citing works
NETISCE: a network-based tool for cell fate reprogramming
Marazzi, L., Shah, M., Balakrishnan, S., Patil, A., & Vera‐Licona, P. (2022) · npj Systems Biology and Applications · doi:10.1038/s41540-022-00231-y · Cited by 17 · see citing works
MicroRNA-302a targets GAB2 to suppress cell proliferation, migration and invasion of glioma
Ma, J., Jia, Y., Liu, J., Yang, X., Lou, M., Liu, J., Feng, F., Ji, P., & Wang, L. (2016) · Oncology Reports · doi:10.3892/or.2016.5320 · Cited by 16 · see citing works
RetractedChinnappan, J., Ramu, A., Vidhya Rajalakshmi, V., & S., A. (2021) · Scientific Reports · doi:10.1038/s41598-021-01508-8 · Cited by 16 · see citing works
Understanding the mechanism of binding between Gab2 and the C terminal SH3 domain from Grb2
Toto, A., Bonetti, D., Simone, A. D., & Gianni, S. (2017) · Oncotarget · doi:10.18632/oncotarget.19323 · Cited by 14 · see citing works
Gab2 Ablation Reverses the Stemness of HER2-Overexpressing Breast Cancer Cells
Zhang, P., Chen, Y., Gong, M., Zhuang, Z., Wang, Y., Mu, L., Wang, T., Pan, J., Liu, Y., Xu, J., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493957 · Cited by 12 · see citing works
Wang, L., Feng, L., He, J., Liu, B., & Sun, J.-G. (2019) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2019347 · Cited by 12 · see citing works
Shen, W., Hou, Y., Yi, Y., Li, F., He, C., & Wang, J. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c02901 · Cited by 10 · see citing works
Determining folding and binding properties of the C‐terminal SH2 domain of SHP2
Nardella, C., Malagrinò, F., Pagano, L., Rinaldo, S., Gianni, S., & Toto, A. (2021) · Protein Science · doi:10.1002/pro.4201 · Cited by 10 · see citing works
Vigoda, M., Mathieson, C., Evans, N. J., Hale, C., Jennings, J., Lucero, O. M., Jeng, S., Bottomly, D., Clayburgh, D. R., Andersen, P. E., et al. (2022) · Cancer Biology & Therapy · doi:10.1080/15384047.2022.2055420 · Cited by 10 · see citing works
Gao, X., Long, R., Qin, M., Zhu, W., Wei, L., Dong, P., Chen, J., Luo, J., & Feng, J. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5327 · Cited by 10 · see citing works
Self-citationUnderstanding the Mechanism of Recognition of Gab2 by the N-SH2 Domain of SHP2
Visconti, L., Malagrinò, F., Pagano, L., & Toto, A. (2020) · Life · doi:10.3390/life10060085 · Cited by 9 · see citing works
Liu, Z., Zhang, X., Xu, M., Dong, M., Liu, Z., Wang, Y., Yu, H., Yu, K., Xu, N., Liu, W., et al. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.04.011 · Cited by 8 · see citing works
Wu, J., Huang, Y., Yu, C., Li, X., Wang, L., Hong, J., Lin, D., Han, X., Guo, G., Hu, T., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.693034 · Cited by 7 · see citing works
Demonstration of Binding Induced Structural Plasticity in a SH2 Domain
Visconti, L., Toto, A., Jarvis, J. A., Troilo, F., Malagrinò, F., Simone, A. D., & Gianni, S. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00089 · Cited by 7 · see citing works
EGFR TKI resistance in lung cancer cells using RNA sequencing and analytical bioinformatics tools
Howell, M., Green, R. J., Cianne, J., Dayhoff, G. W., Uversky, V. N., Mohapatra, S. S., & Mohapatra, S. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2153269 · Cited by 6 · see citing works
Oncogenes in high grade serous adenocarcinoma of the ovary
Manasa, P., Sidhanth, C., Krishnapriya, S., Vasudevan, S., & Ganesan, T. S. (2020) · Genes & Cancer · doi:10.18632/genesandcancer.206 · Cited by 6 · see citing works
Lalruatfela, A., Biswal, P., Behera, S. K., Biswal, S., Behera, D. K., Dash, J. J., & Mallick, B. (2026) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2026.110756 · Cited by 5 · see citing works
Mo, H., Yang, S., & Chen, A. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.08.006 · Cited by 5 · see citing works
Chen, D., Cheng, J., Zhong, Y., Liu, R., Lu, Z., & Luo, X. (2022) · Oncogene · doi:10.1038/s41388-022-02298-7 · Cited by 5 · see citing works
Bufano, M., Puxeddu, M., Nalli, M., Regina, G. L., Toto, A., Liberati, F. R., Paone, A., Cutruzzolà, F., Masci, D., Bigogno, C., et al. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106607 · Cited by 5 · see citing works
Shaban, N., Raevskiy, M., Захарова, Г. С., Shipunova, V. O., Deyev, S. M., Suntsova, M., Sorokin, M., Buzdin, A. A., & Kamashev, D. (2024) · Biochemistry (Moscow) · doi:10.1134/s000629792403009x · Cited by 5 · see citing works
Targeting Adaptation to Cancer Treatment by Drug CombinationsPreprint
Wang, H., Luna, A., Yan, G., Li, X., Babur, Ö., Mills, G. B., Sander, C., & Korkut, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.14.439861 · Cited by 5 · see citing works
Allosteric modulation of Grb2 drives ligand-dependent signal responses
Felice, M. D., Rolfi, L. R., Toso, J., Pennacchietti, V., Ventura, E. S., Toto, A., Tramutola, A., & Gianni, S. (2025) · Biology Direct · doi:10.1186/s13062-025-00656-5 · Cited by 4 · see citing works
DLK1-DIO3 region as a source of tumor suppressor miRNAs in papillary thyroid carcinoma
Alves, L. F., Marson, L. A., Sielski, M. S., Vicente, C. P., Kimura, E. T., & Geraldo, M. V. (2024) · Translational Oncology · doi:10.1016/j.tranon.2023.101849 · Cited by 4 · see citing works
Zhu, X., Chen, X., Zhang, X., Zhao, L., & Shen, X. (2024) · Oncology Letters · doi:10.3892/ol.2024.14353 · Cited by 4 · see citing works
FOXD3 and GAB2 as a pair of rivals antagonistically control hepatocellular carcinogenesis
Liu, R., Sun, Y., Chen, S., Hong, Y. Y., & Lu, Z. (2022) · FEBS Journal · doi:10.1111/febs.16403 · Cited by 4 · see citing works
A heterodimer of α and β hemoglobin chains functions as an innate anticancer agent
Chelladurai, M., Xu, D., Izraely, S., Ben‐Menachem, S., Bengaiev, R., Sagi‐Assif, O., Yuan, W., Pasmanik, M., Hoon, D. S. �., Lu, W., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34702 · Cited by 3 · see citing works
Functional Profiling of Soft Tissue Sarcoma Using Mechanistic Models
Payá‐Milans, M., Peña-Chilet, M., Loucera, C., Esteban‐Medina, M., & Dopazo, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914732 · Cited by 3 · see citing works
Comparative Whole-Genome Sequencing Analysis of In-situ and Invasive Acral Lentiginous Melanoma
Park, H. K., Choi, Y. D., Shim, H. J., Choi, Y., Chung, I. J., & Yun, S. J. (2024) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000002273 · Cited by 3 · see citing works
Zhuang, J., Yu, J., & Yang, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1732214 · Cited by 2 · see citing works
RetractedKramer, M. H., Richardson, S. N., Li, Y., Yin, T.-K., Helton, N. M., George, D. R., Cai, M., Ramakrishnan, S. M., Katerndahl, C., Miller, C. A., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci195929 · Cited by 2 · see citing works
Sandoval, Z. E., Schmidt, R. J., Bhutada, J. S., Shillingford, N., & Zhou, S. (2024) · Pediatric and Developmental Pathology · doi:10.1177/10935266241279073 · Cited by 1 · see citing works
Evaluation of miR-98-5P and GAB2 gene expression in endometriosis
Fazeli, J., Dehghanian, M., Yarahmadi, G., Shirmohamadi, M., Babakhanzadeh, E., & Sheikhha, M. H. (2024) · Gene Reports · doi:10.1016/j.genrep.2024.102121 · Cited by 1 · see citing works
He, J., Kong, Y., Wang, Y., Fang, Q., Wu, H., Du, K., Luo, Y., Tan, J., Yin, H., Lin, H., et al. (2026) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s581550 · Cited by 1 · see citing works
Arkun, Y. (2019) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2019.8857855 · Cited by 1 · see citing works
For a systematic comprehension of GAB2: an analysis based on pan-cancerPreprint
Yin, Y., Guan, Z., Ou, Z., Tang, M., Li, Y., Zhang, C., Zhang, L., & He, A. (2022) · Research Square · doi:10.21203/rs.3.rs-1224365/v1 · Cited by 1 · see citing works
Miyoshi, M., Kawano, S., Zhao, X., Ide, T., & Murakami, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1365848/v1
Seviiri, M. (2022) · Queensland University of Technology · doi:10.5204/thesis.eprints.236969
Gab2 plays a carcinogenic role in ovarian cancer by regulating CrkII
Yin, Y., Zhang, L., Li, Y., Zhang, C., & He, A. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01152-y
Shaban, N., Raevskiy, M., Захарова, Г. С., Shipunova, V. O., Deyev, S. M., Suntsova, M., Sorokin, M., Buzdin, A. A., & Kamashev, D. (2024) · Biochemistry (Moscow) · doi:10.31857/s0320972524030068
Hypoxia-induced HIF-1α enhanced the tumorigenesis in non-small cell lung cancer by targeting GAB2
Zhu, X., Shen, X., Chen, X., Zhang, X., & Gao, W. (2025) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2025.111917
BindingDB (2024) · UC San Diego · doi:10.7270/q2vt1x97
- Authors
- DING, C.-B., YU, W.-N., FENG, J.-H., & LUO, J.-M.
- Venue
- Molecular Medicine Reports
- Publisher
- Spandidos Publications
- Published
- 2015-06-17
- Volume
- 12
- Issue
- 3
- Pages
- 4007-4014
- ISSN
- 1791-2997 (ISSN-L)
- 1791-3004
- PMC
- PMC4526075
- OpenAlex
- W2145250151
- Cited by
- 71
- References
- 84
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 8 · 2023: 5 · 2022: 18 · 2021: 8 · 2020: 4 · 2019: 7 · 2018: 3 · 2017: 6 · 2016: 6
- FWCI
- 0.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Molecular Medicine Reports (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Guizhou Science and Technology Department (2013J2312)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Keywords
- Gab2, docking protein, signal transduction, SH2 domain proteins, SHP2, phosphatidylinositol 3-kinase, PLCγ1, Crk, MAPK signaling, PI3K/Akt signaling, protein-protein interaction, carcinogenesis, breast cancer, leukemia, melanoma, therapeutic target
- MeSH terms
- Humans, Neoplasms, Signal Transduction, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinase Kinases, Adaptor Proteins, Signal Transducing, Phospholipase C gamma, Protein Tyrosine Phosphatase, Non-Receptor Type 11, Protein Interaction Domains and Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
